Dimerix Limited (DXB.AX)
AUD 0.32
(-5.88%)
AUD 0.32
(-5.88%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 583.47 Thousand AUD | -93.46% |
| 2023 | 8.92 Million AUD | 39.21% |
| 2022 | 6.41 Million AUD | 45.91% |
| 2021 | 4.39 Million AUD | 88.84% |
| 2020 | 2.32 Million AUD | 61.32% |
| 2019 | 1.44 Million AUD | 71.98% |
| 2018 | 838.86 Thousand AUD | 51.67% |
| 2017 | 553.09 Thousand AUD | -9.08% |
| 2016 | 608.36 Thousand AUD | 155.56% |
| 2015 | 238.05 Thousand AUD | -9.63% |
| 2014 | 263.4 Thousand AUD | 398.26% |
| 2013 | -88.31 Thousand AUD | 0.0% |
| 2012 | - AUD | -100.0% |
| 2011 | 73.06 Thousand AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | -100.0% |
| 2008 | 442.14 Thousand AUD | -19.05% |
| 2007 | 546.22 Thousand AUD | 96747.52% |
| 2006 | 564.00 AUD | -99.8% |
| 2005 | 286.29 Thousand AUD | -76.22% |
| 2004 | 1.2 Million AUD | 6.78% |
| 2003 | 1.12 Million AUD | -36.78% |
| 2002 | 1.78 Million AUD | -11.84% |
| 2001 | 2.02 Million AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | 0.0% |
| 1997 | - AUD | 0.0% |
| 1996 | - AUD | 0.0% |
| 1995 | - AUD | 0.0% |
| 1994 | - AUD | 0.0% |
| 1993 | - AUD | 0.0% |
| 1992 | - AUD | 0.0% |
| 1991 | - AUD | 0.0% |
| 1990 | - AUD | 0.0% |
| 1989 | - AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | 407.46 Thousand AUD | -95.44% |
| 2024 Q4 | 450.41 Thousand AUD | 0.0% |
| 2024 Q2 | 133.06 Thousand AUD | 0.0% |
| 2023 FY | 8.92 Million AUD | 39.21% |
| 2023 Q2 | - AUD | 0.0% |
| 2023 Q4 | 8.98 Million AUD | 0.0% |
| 2022 Q4 | 6.46 Million AUD | 0.0% |
| 2022 Q2 | - AUD | 0.0% |
| 2022 FY | 6.41 Million AUD | 45.91% |
| 2021 Q4 | 4.3 Million AUD | 0.0% |
| 2021 FY | 4.39 Million AUD | 88.84% |
| 2021 Q2 | 112.37 Thousand AUD | 0.0% |
| 2020 Q2 | 1779.00 AUD | 0.0% |
| 2020 FY | 2.32 Million AUD | 61.32% |
| 2020 Q4 | 2.33 Million AUD | 0.0% |
| 2019 Q2 | 259.53 Thousand AUD | 0.0% |
| 2019 FY | 1.44 Million AUD | 71.98% |
| 2019 Q4 | 1.18 Million AUD | 0.0% |
| 2018 FY | 838.86 Thousand AUD | 51.67% |
| 2018 Q4 | 838.94 Thousand AUD | 0.0% |
| 2018 Q2 | 6348.00 AUD | 0.0% |
| 2017 Q2 | 8351.00 AUD | 0.0% |
| 2017 Q4 | 546.26 Thousand AUD | 0.0% |
| 2017 FY | 553.09 Thousand AUD | -9.08% |
| 2016 Q4 | 582.02 Thousand AUD | 0.0% |
| 2016 FY | 608.36 Thousand AUD | 155.56% |
| 2016 Q2 | 28.24 Thousand AUD | 0.0% |
| 2015 FY | 238.05 Thousand AUD | -9.63% |
| 2015 Q1 | - AUD | 0.0% |
| 2015 Q2 | 35.81 Thousand AUD | 0.0% |
| 2015 Q3 | - AUD | -100.0% |
| 2015 Q4 | 202.23 Thousand AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 FY | 263.4 Thousand AUD | 398.26% |
| 2014 Q3 | - AUD | 0.0% |
| 2014 Q2 | - AUD | 0.0% |
| 2014 Q1 | - AUD | 0.0% |
| 2013 FY | -88.31 Thousand AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2013 Q1 | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2012 FY | - AUD | -100.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2012 Q3 | - AUD | 0.0% |
| 2012 Q2 | - AUD | -100.0% |
| 2012 Q1 | 18.26 Thousand AUD | 0.0% |
| 2011 Q3 | 18.26 Thousand AUD | 0.0% |
| 2011 Q2 | 18.26 Thousand AUD | 0.0% |
| 2011 FY | 73.06 Thousand AUD | 0.0% |
| 2011 Q4 | - AUD | -100.0% |
| 2011 Q1 | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2010 Q3 | - AUD | 0.0% |
| 2010 Q2 | - AUD | 0.0% |
| 2010 Q1 | - AUD | 0.0% |
| 2009 Q1 | 110.53 Thousand AUD | 0.0% |
| 2009 Q2 | - AUD | -100.0% |
| 2009 FY | - AUD | -100.0% |
| 2009 Q3 | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2008 Q1 | 136.55 Thousand AUD | 0.0% |
| 2008 Q2 | 110.53 Thousand AUD | -19.05% |
| 2008 Q4 | - AUD | -100.0% |
| 2008 FY | 442.14 Thousand AUD | -19.05% |
| 2008 Q3 | 110.53 Thousand AUD | -0.0% |
| 2007 Q1 | 141.00 AUD | 0.0% |
| 2007 Q2 | 136.55 Thousand AUD | 96747.52% |
| 2007 Q3 | 136.55 Thousand AUD | 0.0% |
| 2007 Q4 | - AUD | -100.0% |
| 2007 FY | 546.22 Thousand AUD | 96747.52% |
| 2006 Q4 | - AUD | -100.0% |
| 2006 Q2 | 141.00 AUD | -99.8% |
| 2006 Q3 | 141.00 AUD | 0.0% |
| 2006 Q1 | 71.57 Thousand AUD | 0.0% |
| 2006 FY | 564.00 AUD | -99.8% |
| 2005 Q4 | - AUD | -100.0% |
| 2005 Q3 | 71.57 Thousand AUD | -0.0% |
| 2005 Q2 | 71.57 Thousand AUD | -75.66% |
| 2005 FY | 286.29 Thousand AUD | -76.22% |
| 2005 Q1 | 294.1 Thousand AUD | 0.0% |
| 2004 FY | 1.2 Million AUD | 6.78% |
| 2004 Q3 | 294.1 Thousand AUD | -0.0% |
| 2004 Q2 | 294.1 Thousand AUD | 4.15% |
| 2004 Q1 | 282.37 Thousand AUD | 0.0% |
| 2004 Q4 | - AUD | -100.0% |
| 2003 Q3 | 282.37 Thousand AUD | 0.0% |
| 2003 Q1 | 429.94 Thousand AUD | 0.0% |
| 2003 FY | 1.12 Million AUD | -36.78% |
| 2003 Q4 | - AUD | -100.0% |
| 2003 Q2 | 282.37 Thousand AUD | -34.32% |
| 2002 Q4 | - AUD | -100.0% |
| 2002 FY | 1.78 Million AUD | -11.84% |
| 2002 Q1 | 505.59 Thousand AUD | 0.0% |
| 2002 Q2 | 429.94 Thousand AUD | -14.96% |
| 2002 Q3 | 429.94 Thousand AUD | 0.0% |
| 2001 FY | 2.02 Million AUD | 0.0% |
| 2001 Q1 | - AUD | 0.0% |
| 2001 Q2 | 505.6 Thousand AUD | 0.0% |
| 2001 Q3 | 505.59 Thousand AUD | -0.0% |
| 2001 Q4 | - AUD | -100.0% |
| 2000 FY | - AUD | 0.0% |
| 2000 Q4 | - AUD | 0.0% |
| 2000 Q3 | - AUD | 0.0% |
| 2000 Q1 | - AUD | 0.0% |
| 2000 Q2 | - AUD | 0.0% |
| 1999 Q2 | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1999 Q4 | - AUD | 0.0% |
| 1999 Q3 | - AUD | 0.0% |
| 1999 Q1 | - AUD | 0.0% |
| 1998 Q4 | - AUD | 0.0% |
| 1998 Q3 | - AUD | 0.0% |
| 1998 Q2 | - AUD | 0.0% |
| 1998 FY | - AUD | 0.0% |
| 1998 Q1 | - AUD | 0.0% |
| 1997 Q3 | - AUD | 0.0% |
| 1997 Q1 | - AUD | 0.0% |
| 1997 Q4 | - AUD | 0.0% |
| 1997 FY | - AUD | 0.0% |
| 1997 Q2 | - AUD | 0.0% |
| 1996 Q3 | - AUD | 0.0% |
| 1996 Q1 | - AUD | 0.0% |
| 1996 Q4 | - AUD | 0.0% |
| 1996 FY | - AUD | 0.0% |
| 1996 Q2 | - AUD | 0.0% |
| 1995 Q3 | - AUD | 0.0% |
| 1995 Q4 | - AUD | 0.0% |
| 1995 Q2 | - AUD | 0.0% |
| 1995 Q1 | - AUD | 0.0% |
| 1995 FY | - AUD | 0.0% |
| 1994 Q2 | - AUD | 0.0% |
| 1994 Q1 | - AUD | 0.0% |
| 1994 Q4 | - AUD | 0.0% |
| 1994 FY | - AUD | 0.0% |
| 1994 Q3 | - AUD | 0.0% |
| 1993 Q2 | - AUD | 0.0% |
| 1993 Q4 | - AUD | 0.0% |
| 1993 FY | - AUD | 0.0% |
| 1993 Q3 | - AUD | 0.0% |
| 1993 Q1 | - AUD | 0.0% |
| 1992 FY | - AUD | 0.0% |
| 1992 Q1 | - AUD | 0.0% |
| 1992 Q2 | - AUD | 0.0% |
| 1992 Q4 | - AUD | 0.0% |
| 1992 Q3 | - AUD | 0.0% |
| 1991 Q3 | - AUD | 0.0% |
| 1991 Q4 | - AUD | 0.0% |
| 1991 Q1 | - AUD | 0.0% |
| 1991 Q2 | - AUD | 0.0% |
| 1991 FY | - AUD | 0.0% |
| 1990 Q2 | - AUD | 0.0% |
| 1990 Q3 | - AUD | 0.0% |
| 1990 Q4 | - AUD | 0.0% |
| 1990 FY | - AUD | 0.0% |
| 1990 Q1 | - AUD | 0.0% |
| 1989 Q2 | - AUD | 0.0% |
| 1989 FY | - AUD | 0.0% |
| 1989 Q3 | - AUD | 0.0% |
| 1989 Q4 | - AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 50.94 Million AUD | 98.855% |
| Anatara Lifesciences Ltd | -748.91 Thousand AUD | 177.91% |
| Zelira Therapeutics Limited | 10.28 Thousand AUD | -5573.648% |
| Biome Australia Limited | 7.66 Million AUD | 92.392% |
| Patrys Limited | 1.39 Million AUD | 58.149% |
| Orthocell Limited | 3.68 Million AUD | 84.181% |
| Imugene Limited | -5.83 Million AUD | 109.991% |
| Noxopharm Limited | -534.81 Thousand AUD | 209.1% |
| PYC Therapeutics Limited | 22.05 Million AUD | 97.355% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 92.172% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 84.283% |
| Proteomics International Laboratories Limited | -1.12 Million AUD | 151.948% |
| Cynata Therapeutics Limited | 2.31 Million AUD | 74.803% |
| CSL Limited | 15.28 Billion AUD | 99.996% |
| Arovella Therapeutics Limited | -25.97 Thousand AUD | 2345.96% |
| Bio-Gene Technology Limited | -301.44 Thousand AUD | 293.558% |
| Clinuvel Pharmaceuticals Limited | 78.09 Million AUD | 99.253% |
| Starpharma Holdings Limited | 7.65 Million AUD | 92.38% |
| Nanollose Limited | -348.95 Thousand AUD | 267.209% |
| Memphasys Limited | 1606.00 AUD | -36231.133% |
| Invex Therapeutics Ltd | 1.21 Million AUD | 51.868% |
| NeuroScientific Biopharmaceuticals Limited | -91.33 Thousand AUD | 738.819% |
| Amplia Therapeutics Limited | 4.01 Million AUD | 85.452% |
| Botanix Pharmaceuticals Limited | -6.55 Million AUD | 108.906% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | 53.381% |
| Race Oncology Limited | 1.38 Million AUD | 58.021% |
| Nyrada Inc. | -5164.07 AUD | 11398.801% |
| Telix Pharmaceuticals Limited | 308.5 Million AUD | 99.811% |
| PharmAust Limited | -1641.00 AUD | 35656.246% |
| Immutep Limited | 1.44 Million AUD | 59.59% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 94.929% |
| Alterity Therapeutics Limited | 3.8 Million AUD | 84.665% |
| BTC Health Limited | 16.36 Thousand AUD | -3466.491% |
| Acrux Limited | -1.28 Million AUD | 145.442% |
| Neuren Pharmaceuticals Limited | 205.17 Million AUD | 99.716% |
| Biotron Limited | -40.49 Thousand AUD | 1540.758% |
| Tissue Repair Ltd | 150.51 Thousand AUD | -287.665% |
| AdAlta Limited | 1.5 Million AUD | 61.306% |
| Radiopharm Theranostics Limited | -21.3 Million AUD | 102.738% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 460.39 Thousand AUD | -26.734% |
| Paradigm Biopharmaceuticals Limited | 56.81 Thousand AUD | -927.033% |
| Recce Pharmaceuticals Ltd | -366.76 Thousand AUD | 259.086% |
| Avecho Biotechnology Limited | -43.79 Thousand AUD | 1432.294% |
| Actinogen Medical Limited | 9.93 Million AUD | 94.125% |
| Immuron Limited | 3.33 Million AUD | 82.514% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 77.541% |